… In our trial, a lower cutoff level might have resulted in the diagnosis of more prostate cancers
earlier by screening. It has been shown that cancers that are detected by PSA screening at …

… colon; 3) participation in another cancer screening or primary … PLCO trial also excluded men
reporting more than one PSA … results of screening for prostate cancer in the PLCO trial ( 1 ), …

… specific survival for men in the screened group but with a high … prostate cancer screening
trial,4 from one of the centres included in the ERSPC trial, found a risk ratio for prostate cancer …

… screening trial, the US-based Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO)
screening trial, which found no difference in prostate-cancer mortality between men randomised to …

… screening reduces prostate cancer mortality can best be determined on the basis of large
randomized screening trials … the Prostate, Lung, Colorectal and Ovary cancer (PLCO) trial are …

… trial is the largest cancer screening trial ever conducted in the USA. Through four rounds of
screening with PSA and DRE, the PLCO trial … prostate screening. Compared with the baseline …

… prostate cancer mortality, are still several years away. However, the initial screening round of
the PLCO trial … experience with prostate cancer screening of men enrolled in the PLCO trial. …

… to prostate cancer–specific mortality (PCSM) following PSA … one PC death with PSA screening
compared with usual care … randomized population-based PC screening trial 7 in which the …

… for prostate cancer screening indicated that the ranges of probable values at the time the trial
was … , JK: Prostate cancer screening: what we know and what we need to know. Ann. Intern. …

… prostate magnetic resonance imaging could improve the balance of benefits to harm in prostate
cancer screening screening, … resonance imaging in addition to prostate-specific antigen. …